Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

67.36
+2.063.15%
Volume:71.34K
Turnover:4.81M
Market Cap:5.58B
PE:8.66
High:69.02
Open:66.79
Low:66.79
Close:65.30
52wk High:87.50
52wk Low:35.95
Shares:82.77M
Float Shares:72.98M
Volume Ratio:1.06
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.78
EPS(LYR):7.78
ROE:-7740.12%
ROA:23.26%
PB:-27.16
PE(LYR):8.66

Loading ...

PTC Therapeutics Shares Drop After RBC Downgrade

MT Newswires Live
·
Dec 02, 2025

PTC Therapeutics Cut to Sector Perform From Outperform by RBC Capital

Dow Jones
·
Dec 01, 2025

Cadrenal Therapeutics Appoints DR. Lee Golden to Board of Directors

THOMSON REUTERS
·
Dec 01, 2025

RBC Downgrades PTC Therapeutics to Sector Perform From Outperform, Lifts Price Target to $91 From $82

MT Newswires Live
·
Dec 01, 2025

PTC Therapeutics Shares Down 2.1% Premarket After RBC Cuts to Sector Perform From Outperform

THOMSON REUTERS
·
Dec 01, 2025

PTC Therapeutics Director Allan Steven Jacobson Reports Sale of Common Shares

Reuters
·
Nov 27, 2025

PTC Therapeutics Director Emma Reeve Reports Sale of Common Shares

Reuters
·
Nov 26, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Applied Materials, CDW,  Kohl's

Reuters
·
Nov 25, 2025

Why Sandisk Shares Are Rallying Monday After Close

Benzinga_recent_news
·
Nov 25, 2025

PTC Therapeutics Hosts R&D Day to Showcase Pipeline Advances

Reuters
·
Nov 20, 2025

PTC Therapeutics Exec VP and CLO Mark Elliott Boulding Reports Common Stock Sale

Reuters
·
Nov 20, 2025

PTC Therapeutics Director Emma Reeve Reports Disposal of Common Shares

Reuters
·
Nov 15, 2025

Strong Market Penetration and Strategic Pricing Propel PTC Therapeutics to a Buy Rating

TIPRANKS
·
Nov 11, 2025

Cantor Fitzgerald Sticks to Its Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
Nov 05, 2025

PTC Therapeutics Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Nov 05, 2025

RBC Capital Adjusts PTC Therapeutics Price Target to $82 From $70, Maintains Outperform Rating

MT Newswires Live
·
Nov 05, 2025

PTC Therapeutics Inc : Morgan Stanley Raises Target Price to $78 From $71

THOMSON REUTERS
·
Nov 05, 2025

Stock Track | PTC Therapeutics Soars 5.92% on Strong Q3 Results and Successful Sephience Launch

Stock Track
·
Nov 05, 2025

PTC Therapeutics (PTCT) Gets a Buy from Truist Financial

TIPRANKS
·
Nov 05, 2025

S&P 500 Futures Drop In Premarket Trading; Trex Co, Pinterest Lag

Dow Jones
·
Nov 05, 2025